LEMAITRE VASCULAR INC (LMAT)
LEMAITRE VASCULAR INC (LMAT) from its SEC filings: 2025 revenue $249.6 million (+14% vs the year before), net margin 23%, free cash flow $81.3 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $249.6 million |
| Revenue growth | +14% |
| Net income | $57.7 million |
| Net margin | 23.1% |
| Free cash flow | $81.3 million |
| Diluted EPS | $2.52 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +10% |
| Cash | $26.6 million |
| Share count, 1 year | +1% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.